Formosa Pharmaceuticals, Inc. (TPE:6838)

Formosa Pharmaceuticals Revenue

Formosa Pharmaceuticals had revenue of 51.67M TWD in the twelve months ending September 30, 2026, up 324.81% year-over-year. In the year 2025, Formosa Pharmaceuticals had annual revenue of 9.50M, down -93.38%. That makes Formosa Pharmaceuticals the 42,878th largest company in the world by revenue and 2,148th in Taiwan.

• Revenue (ttm): 51.67M
• Revenue Growth: +324.81%
• P/S Ratio: 60.63
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.13B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• America 4.76M 50.2%
• Asia 4.73M 49.8%

Fiscal year ended Dec 31, 2025 See the full Formosa Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.50M	-133.86M	-93.38%
Dec 31, 2024	143.36M	112.18M	359.89%
Dec 31, 2023	31.17M	29.86M	2,270.49%
Dec 31, 2022	1.32M	-27.21M	-95.39%
Dec 31, 2021	28.53M	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error